Protective benefits of AMP-activated protein kinase in hepatic ischemia-reperfusion injury

American Journal of Translational Research

Volumn 9, Issue 3, 2017, Pages 823-829

  Zhang, Min ^a   Yang, Dan ^a   Gong, Xianqiong ^b   Ge, Pu ^a   Dai, Jie ^c   Lin, Ling ^a   Zhang, Li ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Xiamen Hospital of Traditional Chinese Medicine   (China)

^c CHONGQING UNIVERSITY OF ARTS AND SCIENCES   (China)

Author keywords

AMP activated protein kinase; Apoptosis; Hepatic ischemia reperfusion injury; Inflammation; Oxidative stress

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; ADIPONECTIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CASPASE 3; CYSTATHIONINE BETA SYNTHASE; CYTOKINE; HEME OXYGENASE 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MANGANESE SUPEROXIDE DISMUTASE; MATRIX METALLOPROTEINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHR; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

APOPTOSIS; CELL ACTIVATION; ENERGY METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; LIVER ISCHEMIA; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN EXPRESSION; REPERFUSION INJURY; REVIEW;

EID: 85016423689     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Saidi RF and Kenari SK. Liver ischemia/reperfusion injury: an overview. J Invest Surg 2014; 27: 366-379.
2. Karatzas T, Neri AA, Baibaki ME and Dontas IA. Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms. J Surg Res 2014; 191: 399-412.
3. Nastos C, Kalimeris K, Papoutsidakis N, Tasoulis MK, Lykoudis PM, Theodoraki K, Nastou D, Smyrniotis V and Arkadopoulos N. Global consequences of liver ischemia/reperfusion injury. Oxid Med Cell Longev 2014; 2014: 906965.
4. Evans ZP, Mandavilli BS, Ellett JD, Rodwell D, Fariss MW, Fiorini RN, Schnellmann RG, Schmidt MG and Chavin K. Vitamin E succinate enhances steatotic liver energy status and prevents oxidative damage following ischemia/reperfusion. Transplant Proc 2009; 41: 4094-4098.
5. Hardie DG, Schaffer BE and Brunet A. AMPK: an energy-sensing pathway with multiple inputs and outputs. Trends Cell Biol 2016; 26: 190-201.
6. Bertoldo MJ, Faure M, Dupont J and Froment P. AMPK: a master energy regulator for gonadal function. Front Neurosci 2015; 9: 235.
7. Antonioli L, Colucci R, Pellegrini C, Giustarini G, Sacco D, Tirotta E, Caputi V, Marsilio I, Giron MC, Nemeth ZH, Blandizzi C and Fornai M. The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chron ic inflammatory disorders. Expert Opin Ther Targets 2016; 20: 179-191.
8. Steinberg GR and Schertzer JD. AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease. Immunol Cell Biol 2014; 92: 340-345.
9. Peralta C, Bartrons R, Serafin A, Blazquez C, Guzman M, Prats N, Xaus C, Cutillas B, Gelpi E and Rosello-Catafau J. Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 2001; 34: 1164-1173.
10. Liu WY and Jiang RS. Advances in the research of AMPK and its subunit genes. Pak J Biol Sci 2013; 16: 1459-1468.
11. Bright NJ, Thornton C and Carling D. The regulation and function of mammalian AMPK-related kinases. Acta Physiol (Oxf) 2009; 196: 15-26.
12. Oakhill JS, Scott JW and Kemp BE. Structure and function of AMP-activated protein kinase. Acta Physiol (Oxf) 2009; 196: 3-14.
13. Sanz P. AMP-activated protein kinase: structure and regulation. Curr Protein Pept Sci 2008; 9: 478-492.
14. Novikova DS, Garabadzhiu AV, Melino G, Barlev NA and Tribulovich VG. AMP-activated protein kinase: structure, function, and role in pathological processes. Biochemistry (Mosc) 2015; 80: 127-144.
15. Kim J, Yang G, Kim Y, Kim J and Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med 2016; 48: e224.
16. Russo GL, Russo M and Ungaro P. AMP-activated protein kinase: a target for old drugs against diabetes and cancer. Biochem Pharmacol 2013; 86: 339-350.
17. Salminen A, Kaarniranta K and Kauppinen A. Age-related changes in AMPK activation: role for AMPK phosphatases and inhibitory phosphorylation by upstream signaling pathways. Ageing Res Rev 2016; 28: 15-26.
18. Suter M, Riek U, Tuerk R, Schlattner U, Wallimann T and Neumann D. Dissecting the role of 5’-AMP for allosteric stimulation, activation, and deactivation of AMP-activated protein kinase. J Biol Chem 2006; 281: 32207-32216.
19. Wang Y, Nishi M, Doi A, Shono T, Furukawa Y, Shimada T, Furuta H, Sasaki H and Nanjo K. Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett 2010; 584: 1503-1508.
20. Vara D, Salazar M, Olea-Herrero N, Guzman M, Velasco G and Diaz-Laviada I. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy. Cell Death Differ 2011; 18: 1099-1111.
21. Nader N, Ng SS, Lambrou GI, Pervanidou P, Wang Y, Chrousos GP and Kino T. AMPK regulates metabolic actions of glucocorticoids by phosphorylating the glucocorticoid receptor through p38 MAPK. Mol Endocrinol 2010; 24: 1748-1764.
22. Tsai CH, Tsai HC, Huang HN, Hung CH, Hsu CJ, Fong YC, Hsu HC, Huang YL and Tang CH. Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/ p38 signaling pathway in human chondrosarcoma cells. Oncotarget 2015; 6: 258-270.
23. Luo Y and Liu M. Adiponectin: a versatile player of innate immunity. J Mol Cell Biol 2016; 8: 120-128.
24. Qin Y, Li Z, Wang Z, Li Y, Zhao J, Mulholland M and Zhang W. Ghrelin contributes to protection of hepatocellular injury induced by ischaemia/ reperfusion. Liver Int 2014; 34: 567-575.
25. Evankovich J, Zhang R, Cardinal JS, Zhang L, Chen J, Huang H, Beer-Stolz D, Billiar TR, Rosengart MR and Tsung A. Calcium/calmodulin-dependent protein kinase IV limits organ damage in hepatic ischemia-reperfusion injury through induction of autophagy. Am J Physiol Gastrointest Liver Physiol 2012; 303: G189-198.
26. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR, Carlson M and Carling D. Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2: 21-33.
27. Wang G, Yao J, Li Z, Zu G, Feng D, Shan W, Li Y, Hu Y, Zhao Y and Tian X. miR-34a-5p inhibition alleviates intestinal ischemia/reperfusion-induced reactive oxygen species accumulation and apoptosis via activation of SIRT1 signaling. Antioxid Redox Signal 2016; 24: 961-973.
28. Emerling BM, Weinberg F, Snyder C, Burgess Z, Mutlu GM, Viollet B, Budinger GR and Chandel NS. Hypoxic activation of AMPK is dependent on mitochondrial ROS but independent of an increase in AMP/ATP ratio. Free Radic Biol Med 2009; 46: 1386-1391.
29. Paiva MA, Goncalves LM, Providencia LA, Davidson SM, Yellon DM and Mocanu MM. Transitory activation of AMPK at reperfusion protects the ischaemic-reperfused rat myocardium against infarction. Cardiovasc Drugs Ther 2010; 24: 25-32.
30. Decleves AE, Sharma K and Satriano J. Beneficial effects of AMP-activated protein kinase agonists in kidney ischemia-reperfusion: autophagy and cellular stress markers. Nephron Exp Nephrol 2014; [Epub ahead of print].
31. Ruan H and Dong LQ. Adiponectin signaling and function in insulin target tissues. J Mol Cell Biol 2016; 8: 101-109.
32. Ding W, Zhang Q, Dong Y, Ding N, Huang H, Zhu X, Hutchinson S, Gao X and Zhang X. Adiponectin protects the rats liver against chronic intermittent hypoxia induced injury through AMP-activated protein kinase pathway. Sci Rep 2016; 6: 34151.
33. de Boer MP, Meijer RI, Richter EA, van Nieuw Amerongen GP, Sipkema P, van Poelgeest EM, Aman J, Kokhuis TJ, Koolwijk P, van Hinsbergh VW, Smulders YM, Serne EH and Eringa EC. Globular adiponectin controls insulin-mediated vasoreactivity in muscle through AMPKal-pha2. Vascul Pharmacol 2016; 78: 24-35.
34. Zhao L, Fu Z, Wu J, Aylor KW, Barrett EJ, Cao W and Liu Z. Globular adiponectin ameliorates metabolic insulin resistance via AMPK-mediated restoration of microvascular insulin responses. J Physiol 2015; 593: 4067-4079.
35. Zhang C, Liao Y, Li Q, Chen M, Zhao Q, Deng R, Wu C, Yang A, Guo Z, Wang D and He X. Recombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the AMPK/ eNOS pathway. PLoS One 2013; 8: e66382.
36. Grahame Hardie D. AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med 2014; 276: 543-559.
37. O’Neill LA and Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 2013; 493: 346-355.
38. Wu SB, Wu YT, Wu TP and Wei YH. Role of AMPK-mediated adaptive responses in human cells with mitochondrial dysfunction to oxidative stress. Biochim Biophys Acta 2014; 1840: 1331-1344.
39. Qi D and Young LH. AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab 2015; 26: 422-429.
40. Suyavaran A and Thirunavukkarasu C. Preconditioning methods in the management of hepatic ischemia reperfusion-induced injury: update on molecular and future perspectives. Hepatol Res 2017; 47: 31-48.
41. Huynh MK, Kinyua AW, Yang DJ and Kim KW. Hypothalamic AMPK as a regulator of energy homeostasis. Neural Plast 2016; 2016: 2754078.
42. Ross FA, MacKintosh C and Hardie DG. AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours. FEBS J 2016; 283: 2987-3001.
43. Yang CH, Shen YJ, Lai CJ and Kou YR. Inflammatory role of ROS-sensitive AMP-activated protein kinase in the hypersensitivity of lung vagal C fibers induced by intermittent hypoxia in rats. Front Physiol 2016; 7: 263.
44. Ren J, Xu X, Wang Q, Ren SY, Dong M and Zhang Y. Permissive role of AMPK and autophagy in adiponectin deficiency-accentuated myocardial injury and inflammation in endotoxemia. J Mol Cell Cardiol 2016; 93: 18-31.
45. Sag D, Carling D, Stout RD and Suttles J. Adenosine 5’-monophosphate-activated protein kinase promotes macrophage polarization to an anti-inflammatory functional phenotype. J Immunol 2008; 181: 8633-8641.
46. Carroll KC, Viollet B and Suttles J. AMPKalpha1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling. J Leukoc Biol 2013; 94: 1113-1121.
47. Jhun BS, Jin Q, Oh YT, Kim SS, Kong Y, Cho YH, Ha J, Baik HH and Kang I. 5-Aminoimidazole-4-carboxamide riboside suppresses lipopolysaccharide-induced TNF-alpha production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem Biophys Res Commun 2004; 318: 372-380.
48. Zhao X, Zmijewski JW, Lorne E, Liu G, Park YJ, Tsuruta Y and Abraham E. Activation of AMPK attenuates neutrophil proinflammatory activity and decreases the severity of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008; 295: L497-504.
49. van Golen RF, Reiniers MJ, Olthof PB, van Gulik TM and Heger M. Sterile inflammation in hepatic ischemia/reperfusion injury: present concepts and potential therapeutics. J Gastroenterol Hepatol 2013; 28: 394-400.
50. Culmsee C, Monnig J, Kemp BE and Mattson MP. AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 2001; 17: 45-58.
51. Ido Y, Carling D and Ruderman N. Hyperglyce-mia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. Diabetes 2002; 51: 159-167.
52. Cacicedo JM, Benjachareonwong S, Chou E, Yagihashi N, Ruderman NB and Ido Y. Activation of AMP-activated protein kinase prevents lipotoxicity in retinal pericytes. Invest Ophthalmol Vis Sci 2011; 52: 3630-3639.
53. Elias-Miro M, Jimenez-Castro MB, Rodes J and Peralta C. Current knowledge on oxidative stress in hepatic ischemia/reperfusion. Free Radic Res 2013; 47: 555-568.
54. Liu XM, Peyton KJ, Shebib AR, Wang H, Korthuis RJ and Durante W. Activation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival. Am J Physiol Heart Circ Physiol 2011; 300: H84-93.
55. Zimmermann K, Baldinger J, Mayerhofer B, Atanasov AG, Dirsch VM and Heiss EH. Activated AMPK boosts the Nrf2/HO-1 signaling axis--A role for the unfolded protein response. Free Radic Biol Med 2015; 88: 417-426.
56. Awad H, Nolette N, Hinton M and Dakshinamurti S. AMPK and FoxO1 regulate catalase expression in hypoxic pulmonary arterial smooth muscle. Pediatr Pulmonol 2014; 49: 885-897.
57. Yun H, Park S, Kim MJ, Yang WK, Im DU, Yang KR, Hong J, Choe W, Kang I, Kim SS and Ha J. AMP-activated protein kinase mediates the antioxidant effects of resveratrol through regulation of the transcription factor FoxO1. FEBS J 2014; 281: 4421-4438.
58. Alba G, El Bekay R, Alvarez-Maqueda M, Chacon P, Vega A, Monteseirin J, Santa Maria C, Pintado E, Bedoya FJ, Bartrons R and Sobrino F. Stimulators of AMP-activated protein kinase inhibit the respiratory burst in human neutrophils. FEBS Lett 2004; 573: 219-225.
59. Song P and Zou MH. Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems. Free Radic Biol Med 2012; 52: 1607-1619.
60. Ahn YJ, Kim H, Lim H, Lee M, Kang Y, Moon S, Kim HS and Kim HH. AMP-activated protein kinase: implications on ischemic diseases. BMB Rep 2012; 45: 489-495.
61. Sliwinska A and Drzewoski J. Molecular action of metformin in hepatocytes: an updated insight. Curr Diabetes Rev 2015; 11: 175-181.
62. Foretz M, Guigas B, Bertrand L, Pollak M and Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab 2014; 20: 953-966.
63. Asghari A, Akbari G, Meghdadi A and Mortazavi P. Protective effect of metformin on testicular ischemia/reperfusion injury in rats. Acta Cir Bras 2016; 31: 411-416.
64. Wang M, Weng X, Guo J, Chen Z, Jiang G and Liu X. Metformin alleviated EMT and fibrosis after renal ischemia-reperfusion injury in rats. Ren Fail 2016; 38: 614-621.
65. Cahova M, Palenickova E, Dankova H, Sticova E, Burian M, Drahota Z, Cervinkova Z, Kucera O, Gladkova C, Stopka P, Krizova J, Papackova Z, Oliyarnyk O and Kazdova L. Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation. Am J Physiol Gastrointest Liver Physiol 2015; 309: G100-111.
66. Ashabi G, Khalaj L, Khodagholi F, Goudarzvand M and Sarkaki A. Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. Metab Brain Dis 2015; 30: 747-754.
67. Barreto-Torres G, Parodi-Rullan R and Javadov S. The role of PPARalpha in metformin-induced attenuation of mitochondrial dysfunction in acute cardiac ischemia/reperfusion in rats. Int J Mol Sci 2012; 13: 7694-7709.